| mAb | monoclonal antibodies |
| CD | Cluster of differentiation |
| TAM | tumor-associated macrophages |
| MDSC | myeloid-derived suppressor cells |
| TME | tumor microenvironment |
| APM | antigen presenting machinery |
| MHC | major histocompatibility complex |
| TGF-β | transforming growth factor-β |
| IL | interleukin |
| Arg | arginase |
| MSC | mesenchymal stem/stromal cells |
| CAF | cancer-associated fibroblasts |
| EMT | endothelial-to-mesenchymal transition |
| CXCL12 | C-X-C Motif Chemokine Ligand 12 |
| α-SMA | α-smooth muscle actin |
| VEGF | Vascular endothelial growth factor |
| STAT | signal transducer and activator of transcription |
| ERK | extracellular regulated kinase |
| CCL2 | C-C Motif Chemokine Ligand 2 |
| PGE2 | prostaglandin E 2 |
| Tregs | Regulatory T cells |
| APC | antigen-presenting cells |
| HIF1α | hypoxia inducible factor 1α |
| LPS | lipopolysaccharide |
| IFN-γ | interferon gamma |
| MMP9 | matrix metalloproteinase 9 |
| TLR | toll-like receptor |
| M-MDSC | mononuclear MDSC |
| PMN-MDSC | granulocytic or polymorphonuclear MDSC |
| eMDSC | early-stage MDSC |
| LOX1 | lectin-type oxidized low-density lipoprotein receptor 1 |
| iNOS | inducible nitric oxide synthase |
| PDGF | Platelet-derived growth factor |
| IDO | indoleamine 2,3-dioxygenase |
| MET | mesenchymal-to-epithelial transition |
| SDF1 | stromal cell-derived factor 1 |
| HSC | hematopoietic stem cells |
| CMP | common myeloid progenitor cells |
| G-CSF | granulocyte colony-stimulating factor |
| GM-CSF | granulocyte-macrophage colony-stimulating factor |
| IRF8 | Interferon regulatory factor 8 |
| RAGE | receptor for advanced glycation end products |
| TCR | T cell receptor |
| ROS | reactive oxygen species |
| RNS | reactive nitrogen species |
| NO | nitric oxide |
| PNT | peroxynitrite |
| HDAC | histone deacetylase |
| ATRA | all-trans retinoic acid |